Sale!

Immunosuppressant Drug Profile 2 Test

Original price was: $376.Current price is: $238.

-37%

The Immunosuppressant Drug Profile 2 Test is a specialized therapeutic drug monitoring assessment that measures cyclosporine and sirolimus levels in transplant patients. This comprehensive test helps healthcare providers optimize immunosuppressive therapy by ensuring drug concentrations remain within therapeutic ranges, preventing organ rejection while minimizing toxicity risks. Using advanced LC-MS/MS technology, the test provides precise measurements crucial for patients who have undergone organ transplantation. The test costs $238 USD and is essential for maintaining the delicate balance between effective immunosuppression and medication side effects. Results are available same-day when samples are submitted by 5 pm, making it ideal for timely treatment adjustments. This monitoring is particularly important for kidney, liver, and heart transplant recipients who require lifelong immunosuppressive therapy.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

Immunosuppressant Drug Profile 2 Test

Comprehensive Therapeutic Drug Monitoring for Transplant Patients

The Immunosuppressant Drug Profile 2 Test represents a critical advancement in therapeutic drug monitoring for patients undergoing immunosuppressive therapy following organ transplantation. This specialized diagnostic assessment provides healthcare providers with precise measurements of cyclosporine and sirolimus levels, enabling optimal medication management for transplant recipients.

What Does This Test Measure?

The Immunosuppressant Drug Profile 2 Test specifically measures:

  • Cyclosporine Levels: A calcineurin inhibitor that prevents T-cell activation and proliferation
  • Sirolimus Levels: An mTOR inhibitor that blocks T-cell proliferation and antibody production

Using state-of-the-art Liquid Chromatography-Mass Spectrometry/Mass Spectrometry (LC-MS/MS) technology, this test delivers unparalleled accuracy in quantifying these critical immunosuppressive medications. The precision of LC-MS/MS methodology ensures reliable results that form the foundation for appropriate therapeutic decisions.

Who Should Consider This Test?

This test is essential for:

  • Patients who have received organ transplants (kidney, liver, heart, lung)
  • Individuals experiencing symptoms of medication toxicity or underdosing
  • Patients with changing kidney or liver function
  • Those requiring dosage adjustments due to drug interactions
  • Transplant recipients showing signs of organ rejection
  • Patients experiencing side effects from immunosuppressive therapy

Key Benefits of Immunosuppressant Drug Monitoring

Regular monitoring through the Immunosuppressant Drug Profile 2 Test provides numerous advantages:

  • Prevention of Organ Rejection: Ensures adequate drug levels to maintain transplant function
  • Toxicity Reduction: Helps avoid medication-related side effects and organ damage
  • Personalized Treatment: Enables customized dosing based on individual metabolism
  • Early Intervention: Allows prompt adjustment of therapy before complications develop
  • Cost-Effective Care: Prevents expensive hospitalizations due to rejection or toxicity

Understanding Your Test Results

Your test results will provide specific concentration levels for cyclosporine and sirolimus. These values are interpreted in the context of:

  • Therapeutic Range: Optimal drug concentration for efficacy without toxicity
  • Subtherapeutic Levels: Increased risk of organ rejection
  • Supratherapeutic Levels: Higher likelihood of medication side effects
  • Individual Patient Factors: Time since transplant, concurrent medications, and organ function

It’s crucial to discuss your results with your gastroenterologist, nephrologist, or transplant specialist, who will consider your clinical condition, symptoms, and other laboratory findings when making treatment decisions.

Test Pricing and Availability

Test Component Price
Discount Price $238 USD
Regular Price $376 USD

Convenient Testing Across the United States

GGC DNA maintains testing facilities in all major US cities, including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our nationwide network ensures accessible therapeutic drug monitoring for transplant patients regardless of location.

Take Control of Your Transplant Health

Proper monitoring of immunosuppressant drug levels is essential for long-term transplant success. The Immunosuppressant Drug Profile 2 Test provides the critical data needed to maintain the delicate balance between preventing organ rejection and avoiding medication toxicity.

Ready to schedule your test? Call us today at +1(267) 388-9828 or book your appointment online. Our team is available to answer your questions and help you take the next step in managing your transplant health.

Note: Sample collection requires 3 mL (2 mL minimum) whole blood in one Lavender Top (EDTA) tube. For optimal results, samples should be collected just before the next dose (trough levels) and shipped refrigerated. Please provide the date and time of sampling, dose taken, and time of dosing with your sample.